n = 5): The rats in this group were given a daily dose of 25 mg/kg
The most commonly reported adverse events (observed in greater than 5% of clinical trial participants) were nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection-site reactions, fatigue, hypersensitivity reactions, eructation, hair loss and gastroesophageal reflux disease
CCK-8 Assay Chondrocytes were plated at 3 10 3 cells/cm 2 in 24-well microplates with growth medium
Liposomal encapsulation addresses this but only if the liposome particle size and phospholipid composition are correct
Your provider should discuss whether your current treatment plan needs adjustment, what additional interventions might help, and how to prevent further progression